OKAIF.US EvokAI Creative Labs Inc
- Market cap
- USD 908K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2024.
Is OKAIF.US undervalued?
Graham numberThe Graham number of EvokAI Creative Labs Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
EvokAI Creative Labs Inc fundamental analysis
No fundamental analysis for EvokAI Creative Labs Inc yet.
EvokAI Creative Labs Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About EvokAI Creative Labs Inc
EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector. The company's artificial intelligence-enhanced diagnostic profiles provide a basis to monitor mental wellbeing and enable advances in medical diagnoses. It deploys machine learning models to search medical data, integrate novel medical devices, and uncover insights to help improve health outcomes, patient ex…
Full company profileEvokAI Creative Labs Inc financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
EvokAI Creative Labs Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -86.1K | -715K | -2.34M | -1.23M |
| EBITDA | -86.1K | -715K | -17.1M | - |
| Net Income | -86.1K | -715K | -17.1M | -1.25M |
| EPS | -0.01 | -0.01 | -2.25 | -0.16 |
| Balance Sheet | ||||
| Total Assets | 55.3K | 14.8K | 874K | 79.2K |
| Total Liabilities | 0.00 | 215K | 1.16M | 1.06M |
| Shareholders' Equity | 55.3K | -200K | -284K | -977K |
| Cash & Short-term Investments | 5.34K | 4.32K | 774K | 2.95K |
| Cash Flow | ||||
| Operating Cash Flow | -89.7K | -328K | -2.53M | -1.04M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -89.7K | -328K | -2.53M | -1.04M |
| Ratios | ||||
| ROE | -155.5% | - | - | - |
| ROA | -155.5% | -4,829.8% | -1,955.3% | -1,581.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
EvokAI Creative Labs Inc dividends
EvokAI Creative Labs Inc has not paid dividends in the last 3 fiscal years.
Last stock split: 1:10 on Feb 5, 2025.
Who owns EvokAI Creative Labs Inc
Ownership data of EvokAI Creative Labs Inc is not available yet.
EvokAI Creative Labs Inc company profile
- Company name
- EvokAI Creative Labs Inc
- Ticker
- OKAIF.US
- ISIN
- CA30053J2002
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Technology
- Fiscal year end
- December
- Address
- 609 Granville Street, Vancouver, BC, Canada, V7Y 1C3
- Website
- evokailabs.com
About EvokAI Creative Labs Inc
EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector. The company's artificial intelligence-enhanced diagnostic profiles provide a basis to monitor mental wellbeing and enable advances in medical diagnoses. It deploys machine learning models to search medical data, integrate novel medical devices, and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide accurate diagnoses. The company also provides EvokAI Simulators, which combine cognitive neuroscience, virtual reality (VR), and AI technologies to assess cognitive performance and spatial perception; EvokAI Movement Disorder Monitor (MDM) Basic, a wireless and real-time monitor that accurately analyzes the magnitude of movement disorders and the effectiveness of treatments for Parkinson´s disease and other movement disorders, such as dystonia, various diseases causing tremors, Tourette´s syndrome, congenial CP, or MS; and EvokAI MDM PRO, which is used to monitor movement disorders in real time for the accurate surgical results. In addition, it offers EvokAI Neurotrainer, which provides brain health solutions for various ages; and EvokAI Medical, which offers mental wellbeing through AI-driven digital solutions. The company is headquartered in Vancouver, Canada. EvokAI Creative Labs Inc. is a subsidiary of Union Acquisition Group, LLC.
EvokAI Creative Labs Inc management
6- Mr. Alejandro AntalichCEO & Director · born 1974
- Mr. Scott Edwin AckermanCFO, Corporate Secretary & Director · born 1967
- Mr. Rauno JokelainenOperations Manager
- Dr. Georg MeissnerExecutive Vice President of Digital Health Research & Technology
- Ms. Tuula PalmenChief Business Officer
- Mr. Hans J. LauterbachPresident of Europe, Asia Pacific & Middle East